All posts by: Michael Zand

About Michael Zand

Can a Small New Stem Cell Pact Move the Needle for Celgene? – 24/7 Wall St.

Continue reading

2015-04-13 NEWS

24/7 Wall St.

Can a Small New Stem Cell Pact Move the Needle for Celgene?
24/7 Wall St.
Celgene Corp. (NASDAQ: CELG) is one of the world’s top biotech stocks now, and its market cap is nearly $100 billion. The company has made a new investment in a stem cell company in Australia, and 24/7 Wall St. wants to know if this is the sort of
Mix Momentum At Considerable Level- Celgene Corporation (NASDAQ:CELG StreetWise Report

all 8 news articles »